Agencourt Bioscience Corporation Release: Agencourt (R) AMPure (R) Purification System is Validated and Endorsed for Use with the New Affymetrix (Santa Clara, California) Genome-Wide Human SNP Array 5.0

Published: Mar 28, 2007

FULLERTON, Calif. March 28, 2007 - Agencourt Bioscience Corporation, a wholly owned subsidiary of Beckman Coulter, Inc., today announced that Affymetrix Inc. has validated and endorsed the Agencourt AMPure PCR* Purification System for target preparation with the new Genome-Wide Human SNP Array 5.0. The SNP Array 5.0 is Affymetrix's most comprehensive single array for genetic studies, and it is already being used by researchers to better identify and understand complex conditions such as autism, autoimmunity, bipolar disease, cancer, diabetes and heart disease.

Back to news